Since joining the Beetham Eye Institute (BEI) in 1982, Dr. Arrigg has devoted his professional career to providing diabetes eye care with particular emphasis on vitreo-retinal disease and surgery.  Dr. Arrigg is currently an Associate Professor, Department of Ophthalmology, Harvard Medical School, and Chief of Vitreo-Retinal Surgery at the BEI.  As part of his clinical and surgical practice, Dr. Arrigg has access to the latest diagnostic and treatment modalities while performing approximately 150 vitrectomy surgeries per year and conducting multiple intravitreous injection clinics for diabetic macular edema, diabetic retinopathy and macular degeneration. 

Dr. Arrigg is a co-investigator for Diabetic Retinopathy Clinical Research Network (DRCR.net) studies conducted at the BEI and he has been an active participant in numerous federally funded and privatedly funded clinical research studies and trials, including the Diabetes Control and Complication Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) study and numerous trials conducted at the Dana-Farber Cancer Institute.